SCHEMBL29558406

SCHEMBL29558406

NC(=O)C(S)c1cnc(N(c2ccccc2)C2CC2)nc1

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CCR5 P51681 5/20 0.34
▸ KCNA3 P22001 1/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KCNH2 Q12809 1/20 0.32
▸ HDAC1 Q13547 3/20 0.32
▸ CCNK O75909 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CDK12 Q9NYV4 1/20 0.32
▸ OPRD1 P41143 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29558444 0.81 HDAC6 (0.41) MEN1KMT2AHDAC1HDAC6
SCHEMBL29558495 0.72 HDAC6 (0.38) CYP3A4MEN1KMT2AHDAC1OPRD1
SCHEMBL15255066 0.72 KCNA3 (0.39) CCR5KCNA3CYP3A4MEN1KMT2A
SCHEMBL28495234 0.71 HDAC1 (0.65) MEN1KMT2AHDAC1HDAC6
SCHEMBL5463791 0.66 EPHX1 (0.48) —
SCHEMBL3718972 0.65 CYP3A4 (0.43) CCR5CYP3A4MEN1KMT2A
SCHEMBL14640497 0.64 SLC6A2 (0.45) CCR5KCNA3CYP3A4MEN1KMT2A
SCHEMBL11788207 0.64 SLC6A2 (0.45) CCR5KCNA3CYP3A4MEN1KMT2A
SCHEMBL2713930 0.64 OPRM1 (0.39) CCR5CYP3A4KCNH2OPRD1
Hydrochloric Acid SCHEMBL11789965 0.62 SLC6A2 (0.44) CCR5KCNA3CYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111943892-B Histone deacetylase subtype inhibitor thioacetylarylamine compound and application thereof 上海中泽医药科技有限公司 2022-04-05 — — CN claimed
CN-111943892-B Histone deacetylase subtype inhibitor thioacetylarylamine compound and application thereof 上海中泽医药科技有限公司 2022-04-05 — — CN disclosed
Send feedback